YY/T 1516-2017Prolactin quantitative labelling immunoassay kit (English PDF)
泌乳素定量标记免疫分析试剂盒
This is a limited preview
Buy now to download the full PDF (19 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1516-2017 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 28, 2017
Implementation date
April 1, 2018
Scope
YY/T 1516-2017 is the English-translated version of 泌乳素定量标记免疫分析试剂盒.
YY/T 1516-2017 is the Chinese pharmaceutical industry standard for the prolactin assay kit based on a labelled immunoassay.
It sets the requirements, the test methods, the label and instructions for use and the rules for packaging, transport and storage, covering the appearance, the traceability of the calibrator, accuracy, linearity, the detection limit, precision, the hook effect and stability.
It applies to kits that measure prolactin quantitatively in human samples. Issued on 28 March 2017, it has applied since 1 April 2018.
Found what you need?
Document preview — YY/T 1516-2017
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative References4
- 3 Classification4
- 4 Requirements5
- 5 Test Methods7
- 6 Label and Use Instructions9
- 7 Package, Transportation and Storage9
- Bibliography11
1 Scope
This Standard specifies the requirements, test methods, label and use instructions, package, transportation and storage of prolactin quantitative labelling immunoassay kit.
This Standard is applicable to the prolactin quantitative determining kit based on the principle of double antibody sandwich method.
This Standard is not applicable to the prolactin semi-quantitative determining reagent (such as test paper strip, etc.) labelled by colloidal gold or other methods; neither the various prolactin radioimmunoassay or immunoradiometric kits labelled by radioisotopes such as 125I.
2 Normative References
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) are applicable to this document.
GB/T 191-2008 Packaging - Pictorial Marking for Handling of Goods
GB/T 29791.2-2013 In Vitro Diagnostic Medical Devices - Information Supplied by the Manufacturer (Labelling) - Part 2. In Vitro Diagnostic Reagents for Professional
3 Classification
According to the different labelling methods, it can be divided into enzyme labelling, (electro) chemiluminescence labelling, (time-resolved) fluorescent labelling; according to different solid-phase carriers, it can be divided into microporous plate type, tube type, magnetic particles, microspheres, and plastic beads, etc.; according to different operation process, it can be divided into manual operation method and instrument automatic operation method. curve of the kit; the coefficient of variation (CV) of the test results of manual test kit shall be no higher than 10.0%; the coefficient of variation (CV) of the test results of the automatic test kit shall be no higher than 8.0%.
4 Requirements
4.5.2 Between-run precision
Set 2~3 quality control products with different concentration in the dose-response curve range of kit, and between 3 different batches of products; the coefficient of variation (CV) of the test results shall be no higher than 15.0%.
4.6 Specificity
Test the human growth hormone (GH) sample with concentration of 200ng/mL; its test results shall be no higher than 20.0µIU/mL.
4.7 Stability
4.7.1 End-of-shelf-life stability
Store the kit under the specific condition until the end of shelf life; the test results shall conform to the provisions of 4.2, 4.3, 4.4, and 4.5.1.
4.7.2 Thermal stability
Place the kit for a certain period of time at 37°C; the test results shall conform to the provisions of 4.2, 4.3, 4.4, and 4.5.1.
4.7.3 Stability after redissolution of the freeze-dried reagent
Re-dissolve the freeze-dried components in the kit as per the specified conditions; place for a certain period of time under the conditions specified by the manufacturer; the test results shall conform to the provisions of 4.2, 4.3, 4.4, and 4.5.1.
NOTE 1. Generally, products with shelf life of 1 year shall select the products not exceeding 1 month; products with shelf life of half a year shall select the product not exceeding half a month; and so on. However, if the specified time is exceeded, the products are acceptable when they meet the requirements.
NOTE 2. Thermal stability cannot be used to derive the shelf life of products; unless using the derivation formula based on a large number of stability studies.
NOTE 3. According to the product characteristics, one of the above methods of 4.7.1 or 4.7.2 can be selected for verification; however, the selected method shall verify the product stability; so that ensure the product performance in the shelf life meets the standard requirements
NOTE 4. If the kit contains the freeze-dried standard products and the like components; and they shall be placed for certain period of time after redissolution; then it shall carryout the CV- coefficient of variation; s - standard deviation of 10 times test results; x - average value of 10 times test results.
5 Test Methods
5.5.2 Between-run precision
Use the kits with three different batch number to repeat the test for 10 times against the quality control products with different concentration; calculate the average value (x) of the test results and standard deviation (s); calculate the coefficient of variation (CV) as per Formula (4); the results shall conform to the provisions of 4.5.2.
CV- coefficient of variation; s - standard deviation of 30 times test results; x - average value of 30 times test results.
5.6 Specialty
Use the kit buffer system to prepare the specialty sample into the prescribed concentration; parallel determined for twice; its measurement results shall conform to the provision of 4.6.
5.7 Stability
After the kit is stored according to the conditions specified in 4.7, test as per the method stipulated in 5.2, 5.3, 5.4, 5.5.1; the results shall conform to the provisions of 4.7.
6 Label and Use Instructions
It shall conform to the provisions of GB/T 29791.2-2013. […]
7 Package, Transportation and Storage
7.1 Package
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 19 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1516-2017
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
Secure payment via Stripe
Payments accepted
YY/T 1516-2017
$125.00